Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2000 1
2001 4
2002 3
2003 10
2004 11
2005 7
2006 10
2007 21
2008 23
2009 12
2010 25
2011 22
2012 29
2013 34
2014 24
2015 29
2016 23
2017 23
2018 24
2019 28
2020 22
Text availability
Article attribute
Article type
Publication date

Search Results

340 results
Results by year
Filters applied: . Clear all
Page 1
The Oncolytic Virus VSV-GP Is Effective against Malignant Melanoma.
Kimpel J, Urbiola C, Koske I, Tober R, Banki Z, Wollmann G, von Laer D. Kimpel J, et al. Viruses. 2018 Mar 2;10(3):108. doi: 10.3390/v10030108. Viruses. 2018. PMID: 29498639 Free PMC article.
Previously, we described VSV-GP, a modified version of the vesicular stomatitis virus, as a non-neurotoxic oncolytic virus that is effective for the treatment of malignant glioblastoma and ovarian cancer. ...In summary, VSV-GP is a potent candid …
Previously, we described VSV-GP, a modified version of the vesicular stomatitis virus, as a non-neurotoxic oncolytic
Oncotargeting by Vesicular Stomatitis Virus (VSV): Advances in Cancer Therapy.
Bishnoi S, Tiwari R, Gupta S, Byrareddy SN, Nayak D. Bishnoi S, et al. Viruses. 2018 Feb 23;10(2):90. doi: 10.3390/v10020090. Viruses. 2018. PMID: 29473868 Free PMC article. Review.
To specifically address drug-accessibility and chemotherapy side effects, oncolytic virotherapy (OV) has emerged as a novel cancer treatment alternative. ...Among these, the Vesicular stomatitis virus (VSV)-based platform shows high promise, as it is n …
To specifically address drug-accessibility and chemotherapy side effects, oncolytic virotherapy (OV) has emerged as a novel cancer tr …
Oncolytic Vesicular Stomatitis Virus as a Viro-Immunotherapy: Defeating Cancer with a "Hammer" and "Anvil".
Melzer MK, Lopez-Martinez A, Altomonte J. Melzer MK, et al. Biomedicines. 2017 Feb 10;5(1):8. doi: 10.3390/biomedicines5010008. Biomedicines. 2017. PMID: 28536351 Free PMC article. Review.
Vesicular stomatitis virus (VSV), a negative-strand RNA virus, is under intense development as an oncolytic virus due to a variety of favorable properties, including its rapid replication kinetics, inherent tumor specificity, and its pote
Vesicular stomatitis virus (VSV), a negative-strand RNA virus, is under intense development as an oncolytic
The emerging role of oncolytic virus therapy against cancer.
Russell L, Peng KW. Russell L, et al. Chin Clin Oncol. 2018 Apr;7(2):16. doi: 10.21037/cco.2018.04.04. Chin Clin Oncol. 2018. PMID: 29764161 Free PMC article. Review.
Three oncolytic viruses (OVs), an echovirus, an adenovirus, and a herpes simplex-1 virus, have passed governmental regulatory approval in Latvia, China, and the USA and EU. Numerous other recombinant viruses from diverse families are in clinical testing in cancer pa …
Three oncolytic viruses (OVs), an echovirus, an adenovirus, and a herpes simplex-1 virus, have passed governmental regulatory …
TRIM69 Inhibits Vesicular Stomatitis Indiana Virus.
Rihn SJ, Aziz MA, Stewart DG, Hughes J, Turnbull ML, Varela M, Sugrue E, Herd CS, Stanifer M, Sinkins SP, Palmarini M, Wilson SJ. Rihn SJ, et al. J Virol. 2019 Sep 30;93(20):e00951-19. doi: 10.1128/JVI.00951-19. Print 2019 Oct 15. J Virol. 2019. PMID: 31375575 Free PMC article.
Vesicular stomatitis Indiana virus (VSIV), formerly known as vesicular stomatitis virus (VSV) Indiana (VSV(IND)), is a model virus that is exceptionally sensitive to the inhibitory action of interferons (IFNs). ...We
Vesicular stomatitis Indiana virus (VSIV), formerly known as vesicular stomatitis virus (VS
Oncolytic Recombinant Vesicular Stomatitis Virus (VSV) Is Nonpathogenic and Nontransmissible in Pigs, a Natural Host of VSV.
Velazquez-Salinas L, Naik S, Pauszek SJ, Peng KW, Russell SJ, Rodriguez LL. Velazquez-Salinas L, et al. Hum Gene Ther Clin Dev. 2017 Jun;28(2):108-115. doi: 10.1089/humc.2017.015. Hum Gene Ther Clin Dev. 2017. PMID: 28514874 Free PMC article.
Vesicular stomatitis virus (VSV) is a negative-stranded RNA virus that naturally causes disease in livestock including horses, cattle and pigs. The two main identified VSV serotypes are New Jersey (VSNJV) and Indiana (VSIV). VSV is a rapidly rep
Vesicular stomatitis virus (VSV) is a negative-stranded RNA virus that naturally causes disease in livestock inc
Comparative Oncology Evaluation of Intravenous Recombinant Oncolytic Vesicular Stomatitis Virus Therapy in Spontaneous Canine Cancer.
Naik S, Galyon GD, Jenks NJ, Steele MB, Miller AC, Allstadt SD, Suksanpaisan L, Peng KW, Federspiel MJ, Russell SJ, LeBlanc AK. Naik S, et al. Mol Cancer Ther. 2018 Jan;17(1):316-326. doi: 10.1158/1535-7163.MCT-17-0432. Epub 2017 Nov 20. Mol Cancer Ther. 2018. PMID: 29158470 Free PMC article.
Preclinical murine studies demonstrate that single-shot systemic therapy with a vesicular stomatitis virus (VSV)-IFNβ-NIS, a novel recombinant oncolytic VSV, can induce curative remission in tumor-bearing mice. ...This is the first evaluation of intrav …
Preclinical murine studies demonstrate that single-shot systemic therapy with a vesicular stomatitis virus (VSV)-IFNβ-N …
Generation of a Tumor-Specific Chemokine Gradient Using Oncolytic Vesicular Stomatitis Virus Encoding CXCL9.
Eckert EC, Nace RA, Tonne JM, Evgin L, Vile RG, Russell SJ. Eckert EC, et al. Mol Ther Oncolytics. 2019 Dec 14;16:63-74. doi: 10.1016/j.omto.2019.12.003. eCollection 2020 Mar 27. Mol Ther Oncolytics. 2019. PMID: 31930167 Free PMC article.
Genetically modified vesicular stomatitis virus (VSV) is an attractive agent for cancer treatment due to rapid intratumoral replication and observed clinical responses. ...Our results indicate that oncolytic VSV infection promotes release of CXCL9 in t …
Genetically modified vesicular stomatitis virus (VSV) is an attractive agent for cancer treatment due to rapid intratum …
Experimental Evolution Generates Novel Oncolytic Vesicular Stomatitis Viruses with Improved Replication in Virus-Resistant Pancreatic Cancer Cells.
Seegers SL, Frasier C, Greene S, Nesmelova IV, Grdzelishvili VZ. Seegers SL, et al. J Virol. 2020 Jan 17;94(3):e01643-19. doi: 10.1128/JVI.01643-19. Print 2020 Jan 17. J Virol. 2020. PMID: 31694943 Free PMC article.
Vesicular stomatitis virus (VSV) based oncolytic viruses are promising agents against various cancers. We have shown that pancreatic ductal adenocarcinoma (PDAC) cell lines exhibit great diversity in susceptibility and permissibility to VSV. ...Importa
Vesicular stomatitis virus (VSV) based oncolytic viruses are promising agents against various cancers. We have s
Oncolytic vesicular stomatitis virus expressing interferon-γ has enhanced therapeutic activity.
Bourgeois-Daigneault MC, Roy DG, Falls T, Twumasi-Boateng K, St-Germain LE, Marguerie M, Garcia V, Selman M, Jennings VA, Pettigrew J, Amos S, Diallo JS, Nelson B, Bell JC. Bourgeois-Daigneault MC, et al. Mol Ther Oncolytics. 2016 Feb 17;3:16001. doi: 10.1038/mto.2016.1. eCollection 2016. Mol Ther Oncolytics. 2016. PMID: 27119116 Free PMC article.
As a further means to engage the immune system, we engineered a virus, vesicular stomatitis virus (VSV), to encode the proinflammatory cytokine interferon-γ. ...The interferon-γ-encoding virus demonstrated greater activation of dendritic cells a …
As a further means to engage the immune system, we engineered a virus, vesicular stomatitis virus (VSV), to enco …
340 results
Jump to page
Feedback